Biomarker Research

Article	Citations
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes	162
CardioAtlas: deciphering the single-cell transcriptome landscape in cardiovascular tissues and diseases	160
Development and validation of predictive models combining cell-Free DNA motifs and protein biomarkers for early detection of esophageal squamous cell carcinoma and precancerous lesion	148
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients	139
Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma	129
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma	125
Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study	118
Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases	113
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model	97
Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting	90
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology	82
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis	80
Mitochondrial transfer in hematological malignancies	78
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors	76
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer	75
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study	69
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends	68
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy	68
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells	68
Unveiling the potential of CLL-1: a promising target for AML therapy	67
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma	66
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy	66
Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease	65
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk	64
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer	64

Donor T cells for CAR T cell therapy	63
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions	62
p53 biology and reactivation for improved therapy in MDS and AML	62
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients	61
Correction: Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities	61
The role and metabolic adaptations of neutrophils in premetastatic niches	60
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development	59
Identification of urinary bacterial genes as biomarkers for non-invasive diagnosis of renal lupus	58
STAT3–mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis	56
Proteomic and histopathologic profiling reveal molecular features and clinical biomarkers of coronary atherosclerosis	56
The role of BATF in immune cell differentiation and autoimmune diseases	55
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics	53
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages	52
Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study	52
Targeting interleukin-1β and inflammation in lung cancer	52
Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation	51
The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate	50
Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer	49
Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer	49
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions	46
Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas	46
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma	45
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma	43
Transcriptomic analysis of transformed small-cell lung cancer from EGFR-mutated lung adenocarcinoma reveals distinct subgroups and precision therapy opportunities	42
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy	42
BRD4: an effective target for organ fibrosis	42
Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	41
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis	41
Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis	41
Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia	40
Updates on CAR T cell therapy in multiple myeloma	40
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis	40
Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected	39
Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	39
Nucleases as molecular targets for cancer diagnosis	38
Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance	35
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications	35
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study	35
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	34
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors	34
Intratumor microbiome in cancer progression: current developments, challenges and future trends	34
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer	33
The importance of critically short telomere in myelodysplastic syndrome	33
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer	33
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients	32
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers	32
Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy	32
High-throughput LDI MS technology decodes the distinct metabolic landscape of prostate cancer in a large-scale cohort	32
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer	32
Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application	31

Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia	30
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives	29
Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma	29
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy	29
Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma	28
Adipose-derived stem cell exosomes: mechanisms and therapeutic potentials in wound healing	28
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer	28
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives	28
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes	28
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer	27
Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas	27
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives	27
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples	26
RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation	26
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer	26
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma	26
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer	26
Extracellular matrix: unlocking new avenues in cancer treatment	25
New cell sources for CAR-based immunotherapy	25
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives	24
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma	24
FGL1 and FGL2: emerging regulators of liver health and disease	24
Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage	23
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics	23
A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysis	23
Application of double-negative T cells in haematological malignancies: recent progress and future directions	22
T cells in cancer: mechanistic insights and therapeutic advances	22
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification	22
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer	22
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool	22
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia	22
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States	22
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed	22
Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study	22
Human induced-T-to-natural killer cells have potent anti-tumour activities	21
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs	21
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology	21
EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway	21
Correction: CRISPR/Cas-based CAR-T cells: production and application	21
S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome	21
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia	20
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases	20
MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage	20
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer	20
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition	20
SRTdb: an omnibus for human tissue and cancer-specific RNA transcripts	20
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted	19
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications	19
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies	19
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association study	19
A germline FLT3 variant in aplastic anemia	19
Single-cell multi-omics analysis identifies SPP1+ macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy	19
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression	19
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer	19
Targeting TIGIT for cancer immunotherapy: recent advances and future directions	19
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer	18
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma	18
PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals	18
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer	18
PCSK9 in T-cell function and the immune response	18
Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis	18
Oncogenic alterations in advanced NSCLC: a molecular super-highway	18
The significant others of aurora kinase a in cancer: combination is the key	17
MACC1 revisited – an in-depth review of a master of metastasis	17
Cervical cancer heterogeneity: a constant battle against viruses and drugs	17
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications	17
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma	17
Toll-like receptor 3: a double-edged sword	17
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease	17
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies	16
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer	16
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression	16
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA	16
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma	16
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy	16
LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1	16
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets	15
Ribosome profiling: a powerful tool in oncological research	15
Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection	15
Blood and urine biomarkers of disease progression in IgA nephropathy	15

Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects	15
Therapeutic landscape of ovarian cancer: recent advances and emerging therapies	15
The role of pyroptosis in modulating the tumor immune microenvironment	15
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma	14
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes	14
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling	14
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population	14
Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements	14
Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	14
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort	14
Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy	14
Review immune response of targeting CD39 in cancer	14
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia	14
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients	14
Biological roles of RNA m5C modification and its implications in Cancer immunotherapy	13
Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells	13
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation	13
Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer	13
Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (	13
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	13
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects	13
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications	13
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer	13
Sintilimab for the treatment of non-small cell lung cancer	13
Tumor microenvironment and immunotherapy for triple-negative breast cancer	13
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies	13
Gene therapy for polygenic or complex diseases	13
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers	12
Detection of circulating tumor cells: opportunities and challenges	12
Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strat	12
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression	12
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools	12
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond	12
Correction: Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	12
DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction	12
The war between the immune system and the tumor - using immune biomarkers as tracers	12
CRISPR/Cas-based CAR-T cells: production and application	12
Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021	12
Roles of posttranslational modifications in lipid metabolism and cancer progression	12
Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing	12
A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia	12
Biomarkers as targets for CAR-T/NK cell therapy in AML	11
Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging	11
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma	11
Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma	11
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy	11
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021	11
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia	11
Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort	11
Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression	11
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study	11
LRG1, a novel serum biomarker for iMCD disease activity	11
Advances of cancer-associated fibroblasts in liver cancer	10
Untargeted lipidomics reveals racial differences in lipid species among women	10
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis	10
Current challenges and best practices for cell-free long RNA biomarker discovery	10
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma	10
The telomere complex and the origin of the cancer stem cell	10
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML	10
The role of biomarkers in personalized immunotherapy	10
The application of Aptamer in biomarker discovery	10
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy	10
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model	10
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach	10
Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues	10
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma	10
The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance	10
Epigenetic signatures on plasma cell-free DNA to detect kidney allograft rejection in a non-invasive way: development of a 10-plex digital PCR assay	9
The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy	9
Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis	9
Advancement in Multi-omics approaches for Uterine Sarcoma	9
KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma	9
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective	9
Machine learning-based radiomics model: prognostic prediction and mechanism exploration in patients with endometrial cancer	9
Targeting myeloid cells for hematological malignancies: the present and future	9
Bioinformatics tools and data resources for assay development of fluid protein biomarkers	9
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma	9
AXL in myeloid malignancies – an elusive target?	9
Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma	9
Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection	9
Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies	9
The landscape overview of CD47-based immunotherapy for hematological malignancies	9
A comprehensive comparison between camelid nanobodies and single chain variable fragments	9
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies	9
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications	9
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation	8
Single cell analysis identified IFN signaling activation contributes to the pathogenesis of pediatric steroid-sensitive nephrotic syndrome	8
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era	8
X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation	8
Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms	8
Cancer immunotherapy and its facilitation by nanomedicine	8
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells	8
Emerging role of the RNA-editing enzyme ADAR1 in stem cell fate and function	8
Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow	8
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies	8